BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3288947)

  • 1. Aztreonam: review of the clinical experience and potential uses in pediatrics.
    Lebel MH; McCracken GH
    Pediatr Infect Dis J; 1988 May; 7(5):331-9. PubMed ID: 3288947
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of aztreonam in pediatric patients: a review.
    Bosso JA; Black PG
    Pharmacotherapy; 1991; 11(1):20-5. PubMed ID: 1902290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An Italian multicenter study on the efficacy and tolerability of aztreonam in the treatment of urinary tract infections].
    Martelli A; Cortecchia V; Ventriglia L
    Clin Ter; 1988 May; 125(3):191-201. PubMed ID: 2973940
    [No Abstract]   [Full Text] [Related]  

  • 4. Aztreonam in gram-negative infections in children.
    Sklavunu-Tsurutsoglu S; Gatzola-Karaveli M; Hitoglu-Makedu A; Paradelis AG; Tsurutsoglu G
    Chemioterapia; 1987 Jun; 6(2 Suppl):415-7. PubMed ID: 3509461
    [No Abstract]   [Full Text] [Related]  

  • 5. [Moxalactam in pediatrics. Clinical and pharmacokinetic experience. Apropos of 37 cases].
    Bégué P; Safran C; Fleurette J; Brun Y; Floret D; Monnet P
    Sem Hop; 1983 Jun; 59(26):1972-6. PubMed ID: 6310789
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficiency and possibility of the use of aztreonam in bacterial infections caused by gram-negative organisms].
    Caramia G; Compagnoni L; Pettinari A; Gregorini S
    Minerva Pediatr; 1986 Sep; 38(17-18):773-7. PubMed ID: 3796535
    [No Abstract]   [Full Text] [Related]  

  • 7. [Multicenter clinical study and pharmacokinetics of ceftazidime in children and newborn infants].
    Bégué P; Michel B; Chasalette JP; Allouche G; Quinet B
    Pathol Biol (Paris); 1986 May; 34(5):525-9. PubMed ID: 3534737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibiotic treatment in a pediatrics department].
    Hellgren H; Kjellman B
    Lakartidningen; 1978 Jan; 75(4):232-3. PubMed ID: 625172
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic effects and tolerance of aztreonam in infections of the urinary tract in childhood].
    Zappulla F; Mazzanti L; Sandri S; Varoli O; Bernardi F; Villa MP
    G Ital Chemioter; 1985; 32(2):433-6. PubMed ID: 3833585
    [No Abstract]   [Full Text] [Related]  

  • 10. [Report on experience with Binotal in pediatrics].
    Eisenach M
    Med Monatsschr; 1967 Dec; 21(12):563-5. PubMed ID: 5609199
    [No Abstract]   [Full Text] [Related]  

  • 11. [Aztreonam in children with severe infections of the urinary tract].
    Rancilio L; Assael BM; Boccazzi A; Colombo R; Crossignani R; Garlaschi L; Rusconi F
    G Ital Chemioter; 1985; 32(2):437-41. PubMed ID: 3833586
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical study on aztreonam in pediatrics].
    Niino M; Kida K; Matsuda H; Murase M
    Jpn J Antibiot; 1985 Nov; 38(11):3334-42. PubMed ID: 4094066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Respiratory deterioration and allergic bronchopulmonary aspergillosis in cystic fibrosis].
    Salcedo Posadas A
    Enferm Infecc Microbiol Clin; 2000; 18(6):301-3. PubMed ID: 11075497
    [No Abstract]   [Full Text] [Related]  

  • 14. Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients.
    Trujillo H; Harry N; Arango A; Benítez G; Restrepo F; Mejía GI; Castrillón AL
    Chemotherapy; 1989; 35 Suppl 1():25-30. PubMed ID: 2731447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and bacteriologic experimentation with cephradine in pediatrics].
    Malherbe A
    Brux Med; 1974 Feb; 54(2):99-103. PubMed ID: 4434245
    [No Abstract]   [Full Text] [Related]  

  • 16. Aztreonam in the treatment of gram-negative meningitis and other gram-negative infections.
    Feris J; Moledina N; Rodriguez WJ; Khan WN; Puig J; Wiedermann BL; Ahmad S
    Chemotherapy; 1989; 35 Suppl 1():31-8. PubMed ID: 2731448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and bacteriological evaluation of minocycline in mucoviscidosis in children].
    Gilly R; Fougerat J
    Poumon Coeur; 1974; 30(5):375-82. PubMed ID: 4469905
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful response of severe neonatal gram-negative infection to treatment with aztreonam.
    Constantopoulos A; Thomaidou L; Loupa H; Papoulias G
    Chemotherapy; 1989; 35 Suppl 1():101-5. PubMed ID: 2731446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical use of aztreonam.
    Schönwald S; Schoss-Vidensek Z; Car V; Krznar B
    Chemotherapy; 1989; 35 Suppl 1():45-8. PubMed ID: 2731450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections.
    LeFrock JL; Smith BR; Chandrasekar P; Rolston KV; Molavi A; Kannangara W
    Arch Intern Med; 1987 Feb; 147(2):325-8. PubMed ID: 3813751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.